Proveris Scientific Corporation
Sue Farina serves as a Board Member at Proveris Scientific Corporation, where responsibilities include overall operations and strategy to enhance pharmaceutical product development, alongside previous roles as Sr. Vice President & General Counsel. Farina is also a Director on the Board of the YMCA of Greater Boston, participating in both the Audit & Risk and Financial Development Committees. As an Arbitrator for the American Arbitration Association, Farina handles commercial disputes involving major corporations. Farina founded Uneva Health, a digital therapeutics company aimed at improving inhaler use among asthma and COPD patients, and has contributed as an Advisory Board Member to various startups, including WellNested and daytoday health. Past legal experience includes partnership at Hale and Dorr LLP and an associate role at Goldstein & Manello, P.C. Farina earned a JD from Boston College Law School and a BA cum laude in Education from the University of Massachusetts Amherst.
This person is not in the org chart
This person is not in any teams
Proveris Scientific Corporation
Why Proveris Scientific? Proveris helps pharmaceutical companies developing orally inhaled and nasal drug products (OINDPs) reach the market sooner, saving significant time and money. Proveris believes that developing effective OINDP products requires in-depth knowledge and expertise to understand and control the complex relationships among drug delivery devices, formulations, and human usage that drive product performance. Proveris believes that applying intelligent automation technology, modern data analysis, and proven experimentation techniques leads directly to superior product knowledge and to successful therapies reaching patients far sooner than possible any other way. For more than 20 years, Proveris has worked closely with pharmaceutical companies, device suppliers, contract development, research, and manufacturing organizations, and global regulatory agencies who believe in this focus to elevate the standards in the industry and deliver effective therapies. Proveris does extensive product testing to understand the challenges of developing OINDP products and successfully bringing them to market. By working in its own laboratory and with a broad range of industry influencers, Proveris has unique knowledge and experience in synthesizing the complexities of OINDPs to deliver value-oriented solutions to its customers. Through its patented Proveris by Design™ process, Proveris identifies the human usage performance of an OINDP according to current FDA and ICH guidelines for in vitro testing. Proveris assists with pump, valve, and device selection to optimize effective drug delivery, develops testing strategies, conducts method development studies, and delivers and maintains instruments needed for research and on-going quality assurance testing. Proveris is certified to ISO 9001:2015.